Last reviewed · How we verify
PF-07104091 + Fulvestrant (post CDK4/6) — Competitive Intelligence Brief
phase 2
Live · refreshed every 30 min
Target snapshot
PF-07104091 + Fulvestrant (post CDK4/6) (pf-07104091-fulvestrant-post-cdk4-6) — Pfizer Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PF-07104091 + Fulvestrant (post CDK4/6) TARGET | pf-07104091-fulvestrant-post-cdk4-6 | Pfizer Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PF-07104091 + Fulvestrant (post CDK4/6) CI watch — RSS
- PF-07104091 + Fulvestrant (post CDK4/6) CI watch — Atom
- PF-07104091 + Fulvestrant (post CDK4/6) CI watch — JSON
- PF-07104091 + Fulvestrant (post CDK4/6) alone — RSS
Cite this brief
Drug Landscape (2026). PF-07104091 + Fulvestrant (post CDK4/6) — Competitive Intelligence Brief. https://druglandscape.com/ci/pf-07104091-fulvestrant-post-cdk4-6. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab